Compare MLSS & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLSS | ELUT |
|---|---|---|
| Founded | 1989 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9M | 23.3M |
| IPO Year | 1995 | 2020 |
| Metric | MLSS | ELUT |
|---|---|---|
| Price | $0.25 | $1.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $1.00 | ★ $7.00 |
| AVG Volume (30 Days) | 297.3K | ★ 373.8K |
| Earning Date | 11-13-2025 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $8,929,517.00 | ★ $21,746,000.00 |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $7.51 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.59 | ★ 24.08 |
| 52 Week Low | $0.22 | $0.50 |
| 52 Week High | $1.32 | $3.46 |
| Indicator | MLSS | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 35.46 | 63.12 |
| Support Level | $0.26 | $0.89 |
| Resistance Level | $0.30 | $1.07 |
| Average True Range (ATR) | 0.03 | 0.11 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 35.80 | 61.75 |
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.